Data from the private fund ranking network as of October 31, 2026 shows that in October a total of 1,037 private fund institutions participated in research on A-share listed companies, conducting 5,310 research visits in aggregate and covering 463 individual stocks; among them, 58 billion-yuan private funds conducted 704 visits, covering 277 individual stocks. In September the total number of research visits was 1,808, covering 391 individual stocks and 726 institutions, meaning October saw a nearly threefold month-on-month increase. This surge in research activity occurred against the backdrop of a deep market correction. That month the Wind All A index fell 12.44%, and among the 31 Shenwan first-level industries only five — food and beverage, banking, oil and petrochemicals, coal, and home appliances — recorded positive returns, while the communications and electronics industries fell 30.23% and 25.70% respectively, and the power equipment industry dropped 15.88%. Market performance and research intensity formed a clear divergence.
Regarding this phenomenon, Jiao Bing, a researcher at Ge Shang Fund, told reporters that research is a "buy-side research behavior" rather than a "trading sentiment indicator," and the two are inherently out of sync; October coincided with the third-quarter report disclosure window, and a considerable portion of the surge in research visits consisted of institutions' routine actions to verify revenue structure and order visibility. Four Major Sectors Account for Nearly 60%, 183 Stocks Receive Clustered Research
From the perspective of Shenwan first-level industry distribution, in October a total of 13 industries received no fewer than 100 private fund research visits, among which four industries — electronics, pharmaceuticals and biologics, power equipment, and machinery equipment — each exceeded 500 research visits, totaling 3,039 visits and accounting for 57.23% of the month's total research visits. Specifically, the electronics industry was researched 986 times, covering 73 individual stocks; pharmaceuticals and biologics was researched 976 times, covering 62 individual stocks; power equipment was researched 548 times, covering 35 individual stocks; and machinery equipment was researched more than 500 times, covering 52 individual stocks. At the individual stock level, the clustering of institutions was even more pronounced, with 183 stocks receiving no fewer than 10 private fund research visits during the month. In the electronics industry, Yuanjie Semiconductor Technology Co.,Ltd. (ASX: 688498) attracted 100 private fund research visits, with participating institutions including 12 billion-yuan private funds such as Gaoyi Asset and Jinglin Asset; Shenghong Technology received 83 research visits, with 11 billion-yuan private funds including Gaoyi Asset, Panjing Investment, and Juming Investment participating. In the pharmaceuticals and biologics industry, Mindray Medical and United Imaging Medical received 79 and 61 research visits respectively, with 13 and 6 billion-yuan private funds participating in the research; in the power equipment sector, Jinpan Technology and Huashengchang received 64 and 58 research visits respectively, with 4 and 10 billion-yuan private funds participating. In addition, stocks in other industries such as Hikvision, Eoptolink Technology, and Centre Testing International also received 70, 62, and 60 research visits respectively.
Regarding the phenomenon of capital concentrating in high-prosperity tracks, Jiao Bing, a researcher at Ge Shang Fund, told reporters that institutions clustering to research core targets such as Yuanjie Semiconductor Technology Co.,Ltd. (ASX: 688498), Shenghong Technology, and Eoptolink Technology reflects a clear forward-looking intention — using the depth of the decline to verify high-prosperity tracks and prepare for positioning after the adjustment. She said that bottom-area research surges typically go through three stages: "existing coverage, verification research, and targeted deep digging," and the October data has already entered the third stage of "targeted deep digging." However, Jia Xiaolong, director of the Heiqi Capital Research Institute, told reporters that behind the over-57% concentration in the four major sectors, one must guard even more against crowding. He pointed out that intensive research may amplify consensus rather than truth. Institutions' micro-level questions are shifting from asking "how big is the space" to asking "how long until realization, how much cash, how deep the downside," and research during a correction period is about restoring growth narratives to orders, profits, and cash flow; research is the starting point of research, not the prelude to buying.
Small and Mid-Sized Private Funds Run Frequently with High Frequency, Billion-Yuan Private Funds Focus on Core Stocks
In October a total of 130 private fund institutions conducted no fewer than 10 research visits, among which many institutions exceeded 30 research visits. From the perspective of scale distribution, small and mid-sized private funds showed extremely high research frequency. Shenzhen Shangcheng Asset, with assets under management of 0–500 million yuan, topped the list with 103 visits, while Hongsike Asset conducted 92 research visits; billion-yuan private funds were also active, with Gaoyi Asset, Springs Capital, and Juming Investment conducting 77, 63, and 54 research visits respectively. In terms of research paths, institutions of different sizes diverged noticeably. Shenzhen Shangcheng Asset conducted 103 research visits during the month, covering 103 individual stocks, of which 25 were in the pharmaceuticals and biologics industry; among the 92 individual stocks covered by Hongsike Asset, 22 were in the pharmaceuticals and biologics industry. While small and mid-sized private funds cover a broad range, they tend to sink into specific sub-tracks at high frequency. By contrast, billion-yuan private funds cover fewer names but with more prominent focus. Gaoyi Asset conducted 77 research visits, including 13 electronics industry stocks and 11 power equipment industry stocks; Springs Capital conducted 63 research visits, with as many as 27 pharmaceuticals and biologics industry stocks, and researched Huadong Medicine twice; Juming Investment conducted 54 research visits, with 14, 13, and 11 stocks in the electronics, power equipment, and pharmaceuticals and biologics industries respectively.
Regarding this strategic divergence, Jiao Bing, a researcher at Ge Shang Fund, pointed out that the value of small and mid-sized private funds' high-frequency broad coverage lies in being an "information radar," relying on frequent visits to obtain first-hand information, and the coverage direction often leads in reflecting marginal industrial changes, but depth varies and noise is likely; while the value of billion-yuan private funds' focused approach lies in being a "conclusion signal," as top institutions allocate research resources based on already-formed industrial judgments. Jia Xiaolong, director of the Heiqi Capital Research Institute, pointed out that the breadth of small and mid-sized private funds and the depth of billion-yuan private funds are not a matter of high versus low, but a division of labor between discovery and verification. Small and mid-sized institutions' high-frequency broad coverage makes it easier to compare industry prosperity and capture sub-sector changes, yet it is prone to superficial dabbling; billion-yuan private funds' precise deep cultivation can verify technical barriers and earnings quality along the industrial chain, yet may be constrained by existing frameworks. He cautioned that one must guard against breadth turning into a mere cursory look and depth turning into path dependence.
Research Is the Starting Point of Study, Not the Prelude to Buying
Research enthusiasm is high, but a large number of research visits does not equal buying. Jiao Bing, a researcher at Ge Shang Fund, pointed out that research enthusiasm is only a reference for "smart money attention" and not a timing signal; from institutional research to the reflection of related stocks in fund net asset values, there is usually a time lag of more than one quarter. From participating in research to including a company in the stock pool and then to actual investment, there is usually a long decision-making chain. Jia Xiaolong, director of the Heiqi Capital Research Institute, pointed out that institutions typically must go through document review, industrial chain interviews, earnings forecasts and valuation modeling, and then internal review to be included in the observation pool or core stock pool, followed sequentially by investment decision-making, compliance and risk control, portfolio fit, and trade execution, with continuous tracking. What is more capable of driving decisions is the mutual corroboration of orders, revenue, and cash collection, the mutual consistency between management's statements and financial reports, and the ultimate conversion of industry pattern improvement into profit margins and cash flow; all of these influence decisions far more than mere research visit counts and public opinion volume. Jia Xiaolong cautioned that one must guard against the illusion of "much research, little evidence." What is truly valuable is fundamental changes that can be cross-verified and entered into models. Long-termism means respecting evidence amid the noise and identifying genuine industrial progress at the trough; investing is not about chasing companies that the market has already seen, but patiently waiting for value to be proven.
Comments